The DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Underestimation of liver‐related mortality in the United States
Open accessAbstract
Background & aims According to the National Center for Health Statistics (NCHS), chronic liver disease and cirrhosis is the 12(th) leading cause of death in the United States. However, this single descriptor might not adequately enumerate all deaths from liver disease. The aim of our study was to update data on liver mortality in the United States.Methods Mortality data were obtained from the Rochester Epidemiology Project (1999-2008) and the National Death Registry (1979-2008). Liver-specific mortality values were calculated. In contrast to the narrow NCHS definition, updated liver-related causes of death included other specific liver diagnoses (eg, hepatorenal syndrome), viral hepatitis, and hepatobiliary cancers.Results The Rochester Epidemiology Project database contained information on 261 liver-related deaths, with an age- and sex-adjusted death rate of 27.0/100,000 persons (95% confidence interval: 23.7-30.3). Of these, only 71 deaths (27.2%) would have been captured by the NCHS definition. Of cases for which viral hepatitis or hepatobiliary cancer was the cause of death, 96.9% and 94.3% had liver-related immediate causes of death, respectively. In analysis of data from the National Death registry (2008), use of the updated definition increased liver mortality by >2-fold (from 11.7 to 25.7 deaths/100,000, respectively). Using NCHS definitions, liver-related deaths decreased from 18.9/100,000 in 1979 to 11.7/100,000 in 2008-a reduction of 38%. However, using the updated estimate, liver-related deaths were essentially unchanged from 1979 (25.8/100,000) to 2008 (25.7/100,000). Mortality burden was systematically underestimated among non-whites and persons of Hispanic ethnicity.Conclusions Based on analyses of the Rochester Epidemiology Project and National Death databases, liver-related mortality has been underestimated during the past 2 decades in the United States.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, evidence to support integrated behavioral health for patients with chronic liver disease (CLD) is limited.4”
From A Behavioral Health Program for Alcohol Use Disorder, Substance Abuse, and Depression in Chronic Liver Disease (2019) · cites this paper as [4]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El‐Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,384
Chronic hepatitis B: Update 2009 #
Lok, A. S.-F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,836
D'Amico, G., Garcia-Tsao, G., & Pagliaro, L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.013 · Cited by 2,687
Burden of Gastrointestinal Disease in the United States: 2012 Update
Peery, A. F., Dellon, E. S., Lund, J. L., Crockett, S. D., McGowan, C., Bulsiewicz, W. J., Gangarosa, L. M., Thiny, M. T., Stizenberg, K., Morgan, D. R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.002 · Cited by 2,010
History of the Rochester Epidemiology Project
Melton, L. J. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.3.266 · Cited by 1,443
Arvaniti, V., D’Amico, G., Fede, G., Manousou, P., Tsochatzis, E. A., Pleguezuelo, M., & Burroughs, A. K. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.019 · Cited by 1,179
Charlton, M., Burns, J. M., Pedersen, R. A., Watt, K. D. S., Heimbach, J. K., & Dierkhising, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.061 · Cited by 1,115
Younossi, Z. M., Stepanova, M., Afendy, M., Fang, Y. H., Younossi, Y., Mir, H., & Srishord, M. K. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.020 · Cited by 1,072
Hepatocellular carcinoma: Recent trends in the United States
El‐Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.013 · Cited by 971
Flagged first, then by citations
2 of the 45 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–101 of 101
Verma, M., Horrow, J., & Navarro, V. (2019) · Hepatology Communications · doi:10.1002/hep4.1328 · Cited by 23
“(4) CLD is the fourth and seventh leading cause of death among adults ages 45-54 years and 55-64 years, respectively, and is projected to peak in 2021.(5) Compared to other chronic diseases, CLD is associated with higher health care use and worsening mortality over time.”
Background
Metadata
- Authors
- Asrani, S. K., Larson, J. J., Yawn, B., Therneau, T. M., & Kim, W. R.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Kim, W. Ray
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 145
- Issue
- 2
- Pages
- 375-382.e2
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC3890240
- OpenAlex
- W2079748214
- Cited by
- 311
- References
- 45
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 17 · 2023: 30 · 2022: 25 · 2021: 29 · 2020: 27 · 2019: 23 · 2018: 34 · 2017: 28 · 2016: 23 · 2015: 24 · 2014: 23 · 2013: 8
- FWCI
- 16.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (K24DK-92336, R01DK-34238, T32 DK07198)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- liver-related mortality, chronic liver disease, liver cirrhosis, mortality underestimation, cause of death classification, viral hepatitis, hepatobiliary cancer, hepatorenal syndrome, racial and ethnic disparities, Rochester Epidemiology Project
- MeSH terms
- Adult, Aged, Cause of Death, Female, Hepatic Encephalopathy, Hepatitis, Viral, Human, Carcinoma, Hepatocellular, Hepatorenal Syndrome, Humans, Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Male, Middle Aged, Minnesota, National Center for Health Statistics, U.S., United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review